Jian Hua Mo
Director/Board Member chez HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Fortune : 170 M $ au 31/03/2024
Profil
Jian Hua Mo is currently the Director at Hangzhou Binjiang Real Estate Group Co., Ltd.
since 2012.
He is also the Non-Executive Director at Binjiang Service Group Co. Ltd.
since 2017.
Additionally, he holds the position of Executive Director at Shanghai Binshun Investment Management Ltd and Executive Director & General Manager at Hangzhou Binpu Real Estate Development Ltd.
Furthermore, he is the General Manager at Hangzhou Pute Equity Investment Management Ltd.
since 2017.
Previously, Mr. Mo worked as the Director at Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
He also served as the General Manager at Hangzhou Binjiang Venture Captal Investment Ltd.
from 2011 to 2017.
Prior to that, he was the Deputy General Manager at Hangzhou Binjiang Real Estate Construction Co. Ltd.
from 1996 to 1999.
Mr. Mo obtained his MBA from Zhejiang University in 2013.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 35 640 000 ( 12,89% ) | 78 M $ | 31/03/2024 | |
| 30/09/2023 | 75 195 600 ( 17,52% ) | 69 M $ | 31/03/2024 | |
| 30/09/2023 | 25 065 200 ( 0,93% ) | 23 M $ | 31/03/2024 |
Postes actifs de Jian Hua Mo
| Sociétés | Poste | Début |
|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Director/Board Member | 01/05/2012 |
| BINJIANG SERVICE GROUP CO. LTD. | Director/Board Member | 01/12/2017 |
| Shanghai Binshun Investment Management Ltd | Director/Board Member | - |
| Hangzhou Binpu Real Estate Development Ltd. | Director/Board Member | - |
| Hangzhou Pute Equity Investment Management Ltd. | Corporate Officer/Principal | 01/01/2017 |
Anciens postes connus de Jian Hua Mo
| Sociétés | Poste | Fin |
|---|---|---|
| Hangzhou Binjiang Venture Captal Investment Ltd. | Corporate Officer/Principal | 01/11/2017 |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. | Corporate Officer/Principal | 01/12/1999 |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Director/Board Member | - |
Formation de Jian Hua Mo
| Zhejiang University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| BINJIANG SERVICE GROUP CO. LTD. | Finance |
| Entreprise privées | 6 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Shanghai Binshun Investment Management Ltd | |
| Hangzhou Binpu Real Estate Development Ltd. | |
| Hangzhou Pute Equity Investment Management Ltd. | |
| Hangzhou Binjiang Venture Captal Investment Ltd. | |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. |
